Auriga Reiterates a 'Buy' on Myriad Genetics (MYGN); F2Q12 Results: Nice Beat & Raise as Colaris Continues to Surprise
Go back to Auriga Reiterates a 'Buy' on Myriad Genetics (MYGN); F2Q12 Results: Nice Beat & Raise as Colaris Continues to Surprise| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.05 +0.02 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.03 | 52 Week High | $45.34 | |||
| Open | $3.02 | 52 Week Low | $15.92 | |||
| Day High | $3.06 | P/E | 1.31 | |||
| Day Low | $2.97 | EPS | $2.33 | |||
| Volume | 222,365 | |||||
